## BX: Blackstone Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 1.62 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($143.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Blackstone Inc. (NYSE:BX) Given Consensus Rating of "Moderate Buy" by Brokerages**
- Source: MarketBeat | 20251207T040912 | Somewhat-Bullish | Relevance: 99%
-  Blackstone Inc. (NYSE:BX) has received a consensus "Moderate Buy" rating from twenty brokerages, with an average one-year target price of $179.00. Insider Ruth Porat and major shareholder Private Multi-Asset Blackstone have recently increased their stakes in the company, with significant share purchases. The company also announced an increase in its quarterly dividend to $1.29, despite a high dividend payout ratio.

**2. AmTrust and Blackstone Launch ANV Group**
- Source: Program Business | 20251208T140557 | Bullish | Relevance: 99%
-  AmTrust Financial Services and Blackstone Credit & Insurance have launched ANV Group Holdings Ltd., a new independent company formed from a strategic transaction specializing in managing general agencies and fee-based businesses. The ANV Group will operate AmTrust's MGA operations across the United States, United Kingdom, and Continental Europe and has also entered into a 10-year capacity agreement with AmTrust for underwriting existing business. The newly formed ANV Group is led by Adam Karkowsky, formerly president of AmTrust, as Chairman and CEO, and aims to scale its specialty and affinity insurance offerings while acquiring and incubating new MGAs.

**3. Blackstone targets retirement funds for private markets**
- Source: Latest news from Azerbaijan | 20251208T124856 | Bullish | Relevance: 98%
-  Blackstone has launched a new unit to enable retirement savings to flow into private market investments, capitalizing on a significant opportunity in the U.S. This initiative follows a new U.S. executive order aimed at easing alternative asset investments for everyday savers through 401(k) plans. The unit will focus on partnerships and products for defined contribution plans, with Jon Gray emphasizing Blackstone's goal to be the preferred partner for retirement solution providers.

**4. Blackstone, Carlyle, and H&F prepare $5.37bn Medline IPO in one of the largest private equity exits on record**
- Source: Private Equity Insights | 20251209T112524 | Somewhat-Bullish | Relevance: 98%
- Medline, backed by Blackstone, Carlyle, and Hellman & Friedman, is preparing a $5.37bn US IPO, which would be one of the largest private equity-backed listings ever. The offering plans 179 million shares at $26 to $30 each, with significant cornerstone commitments, potentially valuing the company up to $55.3bn. This IPO is set to be a major private equity realization, surpassing previous US listings this year and aiming to revive the US IPO market.

**5. Fayez Sarofim & Co Buys 43,921 Shares of Blackstone Inc. $BX**
- Source: MarketBeat | 20251209T110824 | Somewhat-Bullish | Relevance: 98%
-  Fayez Sarofim & Co increased its stake in Blackstone Inc. by 3.7% during the second quarter, acquiring an additional 43,921 shares. This brings their total ownership to 1,246,371 shares, valued at $186,432,000. Other institutional investors also adjusted their positions, and analysts have issued "Moderate Buy" ratings with a consensus target price of $179.00 for Blackstone.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 9 ($265.98M) |
| Sells | 2 ($19.18M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+1.9%)
- Blackrock Inc.: 6.9% (-1.1%)
- JPMORGAN CHASE & CO: 6.8% (+166.7%)
- Morgan Stanley: 4.4% (+1.8%)
- State Street Corpora: 4.2% (+1.3%)

### Key Risks

1. Heavy insider selling: $19M sold (2 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.62 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 26%, ROA 12%, margin 21%). Balance sheet: $1.6B free cash flow. Revenue growth strong at 26% YoY. Insider buying signal ($266.0M), management confidence. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $185.7B |
| Beta | 1.76 |
| 52W Range | $115.66 - $194.00 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.62 |
| Forward P/E | 23.5 |
| Current P/E | 28.5 |
| YoY Growth | 21.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.0% to 2.9% (+1.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Outperforming sector by 3.3pp, stock-specific strength. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (1.93), confirming momentum. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.85% (CS: 76) | Neutral |
| RSI_14 | 57.8 | Neutral |
| MACD Histogram | 1.93 | Bullish |
| vs SMA20 | 1.049x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.989x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $151.37
- **Stop Loss:** $143.79 (5.0% risk)
- **Target:** $158.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 131
- **Position Value:** $19,829.47
- **Portfolio %:** 19.83%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-29 (Est: $1.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.52 | +23.9% |
| 2025Q2 | $1.10 | $1.21 | +9.8% |
| 2025Q1 | $1.06 | $1.09 | +3.1% |
| 2024Q4 | $1.47 | $1.69 | +15.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*